The National Cancer Institute Opens Clinical Trial Testing Safety and Dosing of NEO-201 Antibody in Patients with Advanced Cancer

Clinical trial tests safety and dosing of NEO-201 antibody in patients with advanced cancer

NIH 11/01/2018
Patients with advanced solid tumors may be eligible to participate in a new clinical trial at the NIH Clinical Center.